Maxim Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-07-2024
- Paid Up Capital ₹ 2.45 M
as on 08-07-2024
- Company Age 25 YEARS, 9 MONTHS
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 38.70 M
as on 08-07-2024
- Revenue 2.32%
FY 2022
- Profit 68.56%
FY 2022
- Ebitda 116.18%
FY 2022
- Net Worth 43.75%
FY 2022
- Total Assets 15.17%
FY 2022
About Maxim Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.45 M.
The company has closed loans amounting to ₹3.87 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tanvir Mahadik, Ashok Dhoka, and Manju Dhoka serve as directors at the Company.
- CIN/LLPIN
U24239PN1998PTC013106
- Company No.
013106
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maxim Pharmaceuticals?
Executive Team (1)
AD
Ashok Dhoka
Managing DirectorAppointment Date: 10-Dec-1998
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Maxim Pharmaceuticals.
Maxim Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.32% increase. The company also saw a substantial improvement in profitability, with a 68.56% increase in profit. The company's net worth Soared by an impressive increase of 43.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxim Pharmaceuticals?
In 2022, Maxim Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Madhurhealth And Nutrition Private Limited
Active
11 years 4 months Ashok Dhoka and Manju Dhoka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 22 Sep 2009 | ₹3.50 Cr | Satisfied |
Central Bak Of India Creation Date: 02 Aug 1999 | ₹3.70 M | Satisfied |
How Many Employees Work at Maxim Pharmaceuticals?
Unlock and access historical data on people associated with Maxim Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxim Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxim Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
